Building A Data Processing Platform With Next-Generation Technology To Increase Business Value Realization

The increased focus on patient outcomes, evidence-based medicines, and decreased costs have put the pharmaceutical industry on the road to continuous innovation. Organizations generate data at each step of this journey, whether it's drug commercialization or post-marketing surveillance. Consequently, there’s “too much” data being generated with exploding data sources and the ever-increasing complexity of pharmaceutical products. This data explosion results in pharmaceutical organizations wading through deep pools of information, sometimes uncertain what they can do with it. More often than not, companies need a next-generation data management platform to store this data efficiently and make sense out of it. It is necessary to ingest the data and generate actionable insights to derive business value, making it crucial for pharma chiefs to invest in developing scalable and agile data management systems to gain effective outcomes.

The good news is – solutions are available! There is software that focuses on enabling key insights across therapeutic areas, brands, market access, patient hub, and commercial teams for superior cross-functional collaboration and insights. And, most importantly, the ability to effortlessly integrate with various tools and technologies, master data management (MDM) platforms, customer relationship management (CRM)/ enterprise resource planning (ERP) systems, and downstream applications.

With Axtria DataMAx^TM, a top-five global pharma has been able to
streamline data to analytics and increase substantial business value by:

Clearing out systemic inefficiencies

Downstream time-lags

Decision downtime through the hierarchy

Read this illustration to know how Axtria brought significant cost savings and operation efficiencies with Axtria DataMAx™.

Contact us at insights@axtria.com with any questions